Exploring Key Insights of the Pelvic Inflammatory Disease (PID) Treatment Market: Growth Prospects, Emerging Trends, and Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the pelvic inflammatory disease (pid) treatment market grown over the years?
In recent times, the market size for the treatment of Pelvic Inflammatory Disease (PID) has witnessed substantial growth. There is an expected growth from $4.49 billion in 2024 to a staggering $4.75 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.8%. Factors such as the increasing prevalence of telemedicine, a surge in instances of sexually transmitted infections, heightened awareness around PID, as well as a boost in healthcare expenditure have contributed to the growth during the historical period.
What Is the forecasted market size and growth rate for the pelvic inflammatory disease (pid) treatment market?
In the coming years, the market size for the treatment of pelvic inflammatory disease (PID) is projected to witness robust growth, with expectations to surge to $5.88 billion in 2029 at a compounded annual growth rate (CAGR) of 5.5%. This growth over the prognosis period can be ascribed to factors such as the rising incidence of sexually transmitted diseases, increased consciousness about women’s reproductive health, education about pelvic inflammatory disease, growing dependency on telehealth services, and a surge in the cases of sexually transmitted infections (STIs). The forecast period is characterized by trends like pioneering treatment products for pelvic inflammatory disease, progress in diagnostic technologies, novel concepts like individualized treatment, sophisticated imaging techniques, and technological advancements.
Get your pelvic inflammatory disease (pid) treatment market report here!
What are the major factors driving growth in the pelvic inflammatory disease (pid) treatment market?
The escalating occurrence of sexually transmitted diseases is predicted to fuel the expansion of the pelvic inflammatory disease (PID) treatment market in the future. Sexually transmitted diseases (STDs) are infections primarily passed on through sexual intercourse, including vaginal, anal, or oral sex, and are caused by bacteria, viruses, or parasites. The rising prevalence of sexually transmitted diseases (STDs) can be attributed to factors like risky sexual practices, unprotected intercourse, inadequate knowledge, late diagnosis, and treatment. Treatment of pelvic inflammatory disease (PID) is effective in handling STDs as it employs antibiotics to eradicate infection-bearing bacteria, preventing further complications like chronic pelvic pain and infertility, and minimizing the probability of recurring infections. For example, a report released by the UK Health Security Agency (UKHSA), a government entity based in the UK, disclosed that in 2023, England noted 6,008 fresh diagnoses of the human immunodeficiency virus (HIV), a surge of 51% compared to the 3,975 diagnoses in 2022. Consequently, the growing occurrence of sexually transmitted infections is catalyzing the expansion of the pelvic inflammatory disease (PID) treatment market.
What key areas define the segmentation of the global pelvic inflammatory disease (pid) treatment Market?
The pelvic inflammatory disease (PID) treatment market covered in this report is segmented –
1) By Treatment Type: Antibiotic Therapy, Surgery, Pain Management, Hormonal Therapy
2) By Route Of Administration: Oral, Intravenous, Intramuscular
3) By End User: Hospitals, Clinics, Homecare
Subsegments:
1) By Antibiotic Therapy: Broad-spectrum Antibiotics, Combination Antibiotic Therapy, Oral Antibiotics, Intravenous Antibiotics
2) By Surgery: Laparoscopy, Hysterectomy, Tubal Surgery
3) By Pain Management: Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Opioid Analgesics, Acetaminophen, Localized Pain Management
4) By Hormonal Therapy: Birth Control Pills, Hormonal Intrauterine Device (IUD), Progesterone Therapy
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21251&type=smp
What are the top market players propelling the growth of the pelvic inflammatory disease (pid) treatment industry?
Major companies operating in the pelvic inflammatory disease (PID) treatment market are Pfizer Inc., Bayer AG, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Mayne Pharma Group Limited, Saphnix Lifesciences, Aristo Pharmaceuticals Pvt. Ltd., Zydus Cadila Healthcare Ltd., Amagen India Life Sciences.
What are the key trends shaping the future of the pelvic inflammatory disease (pid) treatment market?
Key players in the pelvic inflammatory disease (PID) treatment marketplace are concentrating on creating progressive formulations, such as probiotic supplements, to boost treatment potency, reestablish vaginal microbiota equilibrium, and minimize infection recurrence in PID patients. A probiotic supplement encompasses beneficial live yeasts or bacteria, aiding in the preservation or restoration of a healthy balance of gut and vaginal microbiota. Take for example, in November 2024, Lee Health Domain, a pharmaceutical firm based in India, introduced V-Ferin, a probiotic supplement specifically engineered to promote vaginal health. Composed of Lactobacillus acidophilus, lactoferrin peptide, and cranberry extract, V-Ferin’s goal is to restore the natural microbiome and ward off common vaginal infections like bacterial vaginosis and yeast infections. Considering that approximately 25-30% of women suffer from these conditions, which can develop into pelvic inflammatory disease if not treated, V-Ferin presents an innovative way to enhance health and prevent further complications.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21251
What regions are dominating the pelvic inflammatory disease (pid) treatment market growth?
North America was the largest region in the pelvic inflammatory disease (PID) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pelvic inflammatory disease (PID) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
HyperImmune Globulins Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report
Immunoglobulins Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report
Retinal Disorder Treatment Global Market Report 2025
https://thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
